Read how AI-driven quantitative pathology corroborated histological fibrosis improvements in a metabolic-related steatohepatitis trial and strengthened efficacy readouts.
Key Takeaways
- AI qFibrosis analysis assessed 27 protocol-compliant liver biopsies from the trial
- Treated patients achieved ≥1-stage fibrosis improvement in 81.8% versus 18.8% placebo
- Steatosis-corrected qFibrosis scores fell −41.0% with treatment versus +9.5% placebo